文献速递肿瘤 PET/CT

FDG PET/CT影像组学预测局部晚期直肠癌结局

FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-10-18

研究纳入86例局部晚期直肠癌患者,治疗前接受18F-FDG PET/CT纹理分析,评估代谢参数与纹理特征对疾病特异性生存、无病生存和总生存的预测价值。中位随访41个月,纹理参数(coarseness、homogeneity、contrastNGTDM等)为独立预后因素,预测能力强于强度及体积参数。RAS突变状态和TLG为新辅助放化疗后病理反应(TRG 3-4)的显著预测因子。

要点

  • 基线18F-FDG PET/CT纹理分析可独立预测局部晚期直肠癌生存,优于SUV和体积参数。
  • coarseness与DSS和DFS显著相关,homogeneity与DFS相关,contrastNGTDM与OS相关。
  • RAS突变状态和TLG是新辅助放化疗后病理反应(TRG 3-4)的显著预测因子。

核心结论

  • 基线18F-FDG PET/CT纹理分析为局部晚期直肠癌患者生存提供强的独立预测因子,预测能力优于基于强度和体积的参数。
  • 作者认为coarseness等纹理特征的效用应在考虑纳入个体化医学决策算法前通过更大规模临床研究确认。

研究设计与样本

  • 本研究为单中心研究,纳入86例局部晚期直肠癌患者,治疗前接受18F-FDG PET/CT检查。
  • 评估SUVmax、SUVmean、MTV、TLG、直方图强度特征及11个局部和区域纹理特征。
  • 采用Cox回归分析临床、病理和PET代谢参数与DSS、DFS、OS的关系;采用逻辑回归在66例接受新辅助放化疗的患者中预测Dworak肿瘤退缩分级(TRG)定义的病理反应。

主要发现

  • 中位随访41个月,17例(19.7%)出现复发,18例(20.9%)死亡,其中10例死于癌症进展,8例在完全缓解时死于其他原因。
  • DSS在1年、2年、4年分别为95%、93%、87%;多变量分析中体重下降、手术和纹理参数coarseness与DSS显著相关。
  • DFS在1年、2年、4年分别为94%、86%、79%;多变量分析中肿瘤分化和纹理参数homogeneity、coarseness与DFS显著相关。
  • OS在1年、2年、4年分别为93%、87%、79%;cT、手术、SUVmean、dissimilarity和contrastNGTDM与OS显著且独立相关。
  • RAS突变状态(KRAS和NRAS突变)和TLG是新辅助放化疗后病理反应(TRG 3-4)的显著预测因子。

关键数值与推荐

  • DSS:1年95%、2年93%、4年87%;DFS:1年94%、2年86%、4年79%;OS:1年93%、2年87%、4年79%。
  • 中位随访41个月,17例(19.7%)复发,18例(20.9%)死亡。
  • 66例接受新辅助放化疗的患者中,RAS突变状态和TLG为病理反应(TRG 3-4)的显著预测因子。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 作者认为coarseness等纹理特征的效用应在考虑纳入个体化医学决策算法前通过更大规模临床研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to investigate the prognostic value of baseline 18F-FDG PET/CT textural analysis in locally-advanced rectal cancer (LARC). METHODS: Eighty-six patients with LARC underwent 18F-FDG PET/CT before treatment. Maximum and mean standard uptake values (SUVmax and SUVmean), metabolic tumoral volume (MTV), total lesion glycolysis (TLG), histogram-intensity features, as well as 11 local and regional textural features, were evaluated. The relationships of clinical, pathological and PET-derived metabolic parameters with disease-specific survival (DSS), disease-free survival (DFS) and overall survival (OS) were assessed by Cox regression analysis. Logistic regression was used to predict the pathological response by the Dworak tumor regression grade (TRG) in the 66 patients treated with neoadjuvant chemoradiotherapy (nCRT). RESULTS: The median follow-up of patients was 41 months. Seventeen patients (19.7%) had recurrent disease and 18 (20.9 %) died, either due to cancer progression (n = 10) or from another cause while in complete remission (n = 8). DSS was 95% at 1 year, 93% at 2 years and 87% at 4 years. Weight loss, surgery and the texture parameter coarseness were significantly associated with DSS in multivariate analyses. DFS was 94 % at 1 year, 86 % at 2 years and 79 % at 4 years. From a multivariate standpoint, tumoral differentiation and the texture parameters homogeneity and coarseness were significantly associated with DFS. OS was 93% at 1 year, 87% at 2 years and 79% after 4 years. cT, surgery, SUVmean, dissimilarity and contrast from the neighborhood intensity-difference matrix (contrastNGTDM) were significantly and independently associated with OS. Finally, RAS-mutational status (KRAS and NRAS mutations) and TLG were significant predictors of pathological response to nCRT (TRG 3-4). CONCLUSION: Textural analysis of baseline 18F-FDG PET/CT provides strong independent predictors of survival in patients with LARC, with better predictive power than intensity- and volume-based parameters. The utility of such features, especially coarseness, should be confirmed by larger clinical studies before considering their potential integration into decisional algorithms aimed at personalized medicine.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Lovinfosse P, Polus M, Van Daele D, et al. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur J Nucl Med Mol Imaging. 2017. PMID: 29046927. doi:10.1007/s00259-017-3855-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。